4 мар. 2024 г. · The ultimate treatment goal in all patients with peripheral spondyloarthritis (SpA) is to optimize short- and long-term health-related quality of life.

In patients with peripheral spondyloarthritis, the use of methotrexate or sulfasalazine as the first line of treatment is suggested, and local injections of ...

2 мар. 2019 г. · NSAIDs and glucocorticoids are recommended as the first step of treatment in all peripheral manifestations, while conventional synthetic (cs) ...

- NSAIDs and glucocorticoids are recommended as the first step of treatment in all peripheral manifestations, while conventional synthetic DMARDs seem only ...

Treatment for pSpA typically involves a combination of medications, physical therapy, and lifestyle changes. Physiotherapy and light exercise help to maintain ...

27 мая 2023 г. · Peripheral spondyloarthritis is a complex condition that should be followed by a healthcare provider who specializes in the condition. This type ...

13 янв. 2022 г. · Results: In patients with peripheral spondyloarthritis, the use of methotrexate or sulfasalazine as the first line of treatment is suggested, ...

14 мая 2024 г. · Healthcare providers take a stepwise approach to treatment, starting with exercise and over-the-counter (OTC) nonsteroidal anti-inflammatory ...

Treatment agents such as methotrexate, sulfasalazine, leflunomide are recommended as initial therapy for peripheral arthritis and dactylitis in patients with ...